IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)

Dokumenttyp:: Meeting Abstract
Autor(en):: Bellmunt, J; Balar, A; Galsky, MD; Loriot, Y; Theodore, C; Pulido, EG; Castellano, D; Retz, M; Niegisch, G; Bracarda, S; Necchi, A; Vaishampayan, U; Sridhar, S; Eigl, BJ; Hussain, S; van der Heijden, M; Danner, B; Mariathasan, S; Legrand, F; Rosenberg, JE
Titel:: IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
Zeitschriftentitel:: Ann Oncol
Jahr:: 2016
Band / Volume:: 27 6
Seitenangaben Beitrag:: -
Sprache:: eng
Print-ISSN:: 0923-7534
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: